Hedgehog signalling is involved in acquired resistance to KRASG12C inhibitors in lung cancer cells
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Although KRAS G12C inhibitors have shown promising activity in lung adenocarcinomas harbouring KRAS G12C, acquired resistance to these therapies eventually occurs in most patients. Re-expression of KRAS is thought to be one of the main causes of acquired resistance. However, the mechanism through which cancer cells re-express KRAS is not fully understood. Here, we report that the Hedgehog signal is induced by KRAS G12C inhibitors and mediates KRAS re-expression in cancer cells treated with a KRAS G12C inhibitor. Further, KRAS G12C inhibitors induced the formation of primary cilia and activated the Hedgehog-GLI-1 pathway. GLI-1 binds to the KRAS promoter region, enhancing KRAS promoter activity and KRAS expression. Inhibition of GLI using siRNA or the smoothened (Smo) inhibitor suppressed re-expression of KRAS in cells treated with a KRAS G12C inhibitor. In addition, we demonstrate that KRAS G12C inhibitors decreased Aurora kinase A (AURKA) levels in cancer cells, and inhibition of AURKA using siRNA or inhibitors led to increased expression levels of GLI-1 and KRAS even in the absence of KRAS inhibitor. Ectopic expression of AURKA attenuated the effect of KRAS G12C inhibitors on the expression of GLI-1 and re-expression of KRAS. Together, these findings demonstrate the important role of AURKA, primary cilia, and Hedgehog signals in the re-expression of KRAS and therefore the induction of acquired resistance to KRAS G12C inhibitors, and provide a rationale for targeting Hedgehog signalling to overcome acquired resistance to KRAS G12C inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, AURKA was also found to be involved in regulating the Hedgehog/GLI-1 signaling axis, which promotes KRAS re-expression and escape from KRAS G12C inhibition in NSCLC cells [138].”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256 · cited 1×
“A KRAS G12C mutation results in an increase of GTP-bound activated KRAS [8] and activates downstream signaling pathways that allow cells to grow uncontrollably [9].”
BackgroundThe Clinical KRAS(G12C) Inhibitor AMG 510 Drives Anti-Tumour Immunity
Canon, J., Rex, K., Saiki, A. Y., Mohr, C., Cooke, K., Bagal, D., Gaida, K., Holt, T., Knutson, C. G., Koppada, N., et al. (2019) · Nature · doi:10.1038/s41586-019-1694-1 · Cited by 2,277
The Guanine Nucleotide-Binding Switch in Three Dimensions
Vetter, I. R., & Wittinghofer, A. (2001) · Science · doi:10.1126/science.1062023 · Cited by 1,875 · cited 1×
“The binding of GTP to KRAS promotes the binding of effectors that trigger signal transduction pathways, including the RAF-MEK-ERK (MAPK) pathway [2, 3].”
BackgroundThe mechanisms of Hedgehog signalling and its roles in development and disease
Briscoe, J., & Thérond, P. P. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3598 · Cited by 1,751 · cited 2×
“We con fi rmed the RNA-seq results by conducting qRT-PCR ampli fi cation and western blot assays.”
BackgroundMethodKRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors
Hong, D. S., Fakih, M. G., Strickler, J. H., Desai, J., Durm, G. A., Shapiro, G. I., Falchook, G. S., Price, T. J., Sacher, A., Denlinger, C. S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1917239 · Cited by 1,733
The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., & Wittinghofer, A. (1997) · Science · doi:10.1126/science.277.5324.333 · Cited by 1,543 · cited 1×
“Activating mutations in the KRAS gene are a hallmark of cancer [4] and the KRAS G12C protein mutation is one of the most common activating alterations in lung adenocarcinoma [5].”
BackgroundEfficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,464
Patched1 Regulates Hedgehog Signaling at the Primary Cilium
Rohatgi, R., Milenkovic, L., & Scott, M. P. (2007) · Science · doi:10.1126/science.1139740 · Cited by 1,426
Hedgehog signalling in the mouse requires intraflagellar transport proteins
Huangfu, D., Liu, A., Rakeman, A. S., Murcia, N. S., Niswander, L., & Anderson, K. V. (2003) · Nature · doi:10.1038/nature02061 · Cited by 1,425
Acquired Resistance to KRAS G12C Inhibition in Cancer
Awad, M. M., Liu, S., Rybkin, I. I., Arbour, K. C., Dilly, J., Zhu, V. W., Johnson, M. L., Heist, R. S., Patil, T., Riely, G. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105281 · Cited by 1,247
Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor
Janes, M. R., Zhang, J., Li, L.-S., Hansen, R., Peters, U., Guo, X., Chen, Y., Babbar, A., Firdaus, S. J., Darjania, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.006 · Cited by 1,172
Hedgehog Signaling in Development and Cancer
Jiang, J., & Hui, C.-C. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.11.010 · Cited by 1,063
Milburn, M. V., Tong, L., deVos, A. M., Brünger, A., Yamaizumi, Z., Nishimura, S., & Kim, S.-H. (1990) · Science · doi:10.1126/science.2406906 · Cited by 1,059
HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary Cilium
Pugacheva, E. N., Jablonski, S. A., Hartman, T. R., Henske, E. P., & Golemis, E. A. (2007) · Cell · doi:10.1016/j.cell.2007.04.035 · Cited by 890
The Graded Response to Sonic Hedgehog Depends on Cilia Architecture
Caspary, T., Larkins, C. E., & Anderson, K. V. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.03.004 · Cited by 727 · cited 1×
“After blocking the cells with 5% bovine serum albumin (BSA) in PBS, the cells were incubated overnight at 4 °C with primary antibodies against acetylated α -tubulin (T7451, Sigma-Aldrich) and a small GTPase Arl13B enriched in primary cilia [27] (17711-1-AP, Proteintech) in 1% BSA.”
MethodAllele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
Lito, P., Solomon, M., Li, L.-S., Hansen, R., & Rosen, N. (2016) · Science · doi:10.1126/science.aad6204 · Cited by 691
Sasaki, H., Hui, C.-C., Nakafuku, M., & Kondoh, H. (1997) · Development · doi:10.1242/dev.124.7.1313 · Cited by 674
Primary Cilia and Mammalian Hedgehog Signaling
Bangs, F., & Anderson, K. V. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028175 · Cited by 642 · cited 1×
“Vertebrate Hh signaling is transduced by the primary cilium, a cellular antenna that projects from the surface of most cells [22, 23].”
BackgroundRapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
Xue, J. Y., Zhao, Y., Aronowitz, J., Mai, T. T., Vides, A., Qeriqi, B., Kim, D., Li, C., de Stanchina, E., Mazutis, L., et al. (2020) · Nature · doi:10.1038/s41586-019-1884-x · Cited by 543
Tanaka, N., Lin, J. J., Li, C., Ryan, M. B., Zhang, J., Kiedrowski, L. A., Michel, A. G., Syed, M. U., Fella, K. A., Sakhi, M., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0365 · Cited by 527 · cited 1×
“…inhibitors can be caused by various mechanisms [15], including genetic changes such as secondary mutations in KRAS G12C that interfere with the binding of covalent inhibitors to cysteine 12 residues, and other mutations related to the reactivation of the RAS-RAF-MEK-ERK signaling pathway [16, 17].”
BackgroundKatoh, Y., & Katoh, M. (2009) · Current Molecular Medicine · doi:10.2174/156652409789105570 · Cited by 525
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
Ryan, M. B., Fece de la Cruz, F., Phat, S., Myers, D. T., Wong, E., Shahzade, H. A., Hong, C. B., & Corcoran, R. B. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3523 · Cited by 496 · cited 1×
“However, another study suggests that wild-type RAS activation mediated by multiple-receptor tyrosine kinases ( RTKs), rather than a single RTK, is responsible for acquired resistance to the KRAS G12C inhibitors ARS-1620 and sotorasib in various cancer cell lines [20].”
BackgroundSonic Hedgehog-induced Activation of the Gli1Promoter Is Mediated by GLI3
Dai, P., Akimaru, H., Tanaka, Y., Maekawa, T., Nakafuku, M., & Ishii, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8143 · Cited by 466
Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E
Duman-Scheel, M., Weng, L., Xin, S., & Du, W. (2002) · Nature · doi:10.1038/417299a · Cited by 434
A model for RAS mutation patterns in cancers: finding the sweet spot
Li, S., Balmain, A., & Counter, C. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0076-6 · Cited by 384
Nolan-Stevaux, O., Lau, J., Truitt, M. L., Chu, G. C., Hebrok, M., Fernández-Zapico, M. E., & Hanahan, D. (2009) · Genes & Development · doi:10.1101/gad.1753809 · Cited by 383
Centriole ciliation is related to quiescence and DNA synthesis in 3T3 cells
Tucker, R. W., Pardee, A. B., & Fujiwara, K. (1979) · Cell · doi:10.1016/0092-8674(79)90261-7 · Cited by 366
Dennler, S., André, J., Alexaki, I., Li, A., Magnaldo, T., ten Dijke, P., Wang, X.-J., Verrecchia, F., & Mauviel, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0491 · Cited by 342
The aurora kinases in cell cycle and leukemia
Goldenson, B., & Crispino, J. D. (2015) · Oncogene · doi:10.1038/onc.2014.14 · Cited by 334
Jia, J., Tong, C., Wang, B., Luo, L., & Jiang, J. (2004) · Nature · doi:10.1038/nature03179 · Cited by 333
Pietrobono, S., Gagliardi, S., & Stecca, B. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00556 · Cited by 303
The current understanding of KRAS protein structure and dynamics
Pantsar, T. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.004 · Cited by 282 · cited 1×
“KRAS proteins have relatively smooth surfaces, no obvious deep hydrophobic pockets to which drugs can bind [10], and high af fi nity for GTPs, which make it dif fi cult to interfere with GTP binding using GTP analogs [11].”
BackgroundCilium assembly and disassembly
Sánchez, I., & Dynlacht, B. D. (2016) · Nature Cell Biology · doi:10.1038/ncb3370 · Cited by 278
Review: Targeting the Hedgehog pathway in cancer
Gupta, S., Takebe, N., & LoRusso, P. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010366430 · Cited by 259
Biochemical mechanisms of vertebrate hedgehog signaling
Kong, J. H., Siebold, C., & Rohatgi, R. (2019) · Development · doi:10.1242/dev.166892 · Cited by 241 · cited 1×
“In the absence of Hh ligands, the Hh receptors patched 1 (PTCH1) and PTCH2 at the cilium inhibit Smo, keeping the pathway in its off state [24].”
BackgroundTargeting KRAS(G12C): From Inhibitory Mechanism to Modulation of Antitumor Effects in Patients
Kim, D., Xue, J. Y., & Lito, P. (2020) · Cell · doi:10.1016/j.cell.2020.09.044 · Cited by 239 · cited 1×
“KRAS G12C mutations occur in approximately 13% of lung adenocarcinomas and 3% of colorectal adenocarcinomas, and are less commonly in cancers of the uterus, pancreas, breast, bladder, cervix, and ovaries [6, 7].”
BackgroundThe KRAS-G12C inhibitor: activity and resistance
Liu, J., Kang, R., & Tang, D. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-021-00383-9 · Cited by 219
Distribution of KRAS G12C Somatic Mutations across Race, Sex, and Cancer Type
Nassar, A. H., Adib, E., & Kwiatkowski, D. J. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2030638 · Cited by 210 · cited 1×
“KRAS G12C mutations occur in approximately 13% of lung adenocarcinomas and 3% of colorectal adenocarcinomas, and are less commonly in cancers of the uterus, pancreas, breast, bladder, cervix, and ovaries [6, 7].”
BackgroundStructural Basis of Smoothened Activation in Hedgehog Signaling
Huang, P., Zheng, S., Wierbowski, B. M., Kim, Y., Nedelcu, D., Aravena, L., Liu, J., Kruse, A. C., & Salic, A. (2018) · Cell · doi:10.1016/j.cell.2018.04.029 · Cited by 176
Ikram, M. S., Neill, G. W., Regl, G., Eichberger, T., Frischauf, A.-M., Aberger, F., Quinn, A., & Philpott, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22612.x · Cited by 171
Peterson, K. A., Nishi, Y., Ma, W., Vedenko, A., Shokri, L., Zhang, X., McFarlane, M., Baizabal, J.-M., Junker, J. P., van Oudenaarden, A., et al. (2012) · Genes & Development · doi:10.1101/gad.207142.112 · Cited by 170
Dummer, R., Guminski, A., Gutzmer, R., Dirix, L., Lewis, K. D., Combemale, P., Herd, R. M., Kaatz, M., Loquai, C., Stratigos, A. J., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.02.1226 · Cited by 164
How the Ciliary Membrane Is Organized Inside-Out to Communicate Outside-In
Garcia, G., Raleigh, D. R., & Reiter, J. F. (2018) · Current Biology · doi:10.1016/j.cub.2018.03.010 · Cited by 162
Genetic and biochemical definition of the Hedgehog receptor
Zheng, X., Mann, R. K., Sever, N., & Beachy, P. A. (2010) · Genes & Development · doi:10.1101/gad.1870310 · Cited by 129
The emergent design of the neural tube: prepattern, SHH morphogen and GLI code
Ruiz i Altaba, A., Nguyên, V., & Palma, V. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.08.005 · Cited by 118
Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition
Tsai, Y. S., Woodcock, M. G., Azam, S. H., Thorne, L. B., Kanchi, K. L., Parker, J. S., Vincent, B. G., & Pecot, C. V. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155523 · Cited by 103
Affinity Profiling of the Cellular Kinome for the Nucleotide Cofactors ATP, ADP, and GTP
Becher, I., Savitski, M. M., Savitski, M. F., Hopf, C., Bantscheff, M., & Drewes, G. (2013) · ACS Chemical Biology · doi:10.1021/cb3005879 · Cited by 94
Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition
Tsai, Y., Woodcock, M. G., Azam, S. H., Thorne, L. B., Kanchi, K., Parker, J. S., Vincent, B. G., & Pecot, C. V. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 87
Cully, M., & Downward, J. (2008) · Cell · doi:10.1016/j.cell.2008.06.020 · Cited by 80
Deconstructing the Hedgehog Pathway in Development and Disease
Jacob, L. S., & Lum, L. (2007) · Science · doi:10.1126/science.1147314 · Cited by 79
Non-consensus GLI binding sites in Hedgehog target gene regulation
Winklmayr, M., Schmid, C., Laner‐Plamberger, S., Kaser-Eichberger, A., Aberger, F., Eichberger, T., & Frischauf, A. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-2 · Cited by 73
Structural Basis of Smoothened Activation in Hedgehog Signaling
Huang, P., Zheng, S., Wierbowski, B. M., Kim, Y., Nedelcu, D., Aravena, L., Liu, J., Kruse, A. C., & Salic, A. N. (2018) · Cell · doi:10.1016/j.cell.2018.09.003 · Cited by 58 · cited 1×
“When Hh ligands bind to their receptor PTCHs at the cilium, inhibition of Smo ceases and Smo accumulates at the cilium, where it activates the downstream pathway [25].”
BackgroundHEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth
Pandolfi, S., Montagnani, V., Lapucci, A., & Stecca, B. A. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.56 · Cited by 44
Cited by
Jiang, C., Xie, S., Jia, K., Feng, G., Ren, X., & Wang, Y. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101179 · Cited by 20
Kale, R. R., Samant, C., Nandakumar, K., Pai, K. S. R., & Bhonde, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151688 · Cited by 12
Bhattacharya, D., Roman, B., & Reddy, S. (2026) · Cancer Gene Therapy · doi:10.1038/s41417-026-01003-0 · Cited by 11
Differential Response and Resistance to KRAS-Targeted Therapy
Liu, Z., Lenz, H., Yu, J., & Zhang, L. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.23908 · Cited by 7
“Additionally, AURKA was also found to be involved in regulating the Hedgehog/GLI ‐ 1 signaling axis, which promotes KRAS re ‐ expression and escape from KRAS G12C inhibition in NSCLC cells [141].”
Huang, R., Gong, X., Du, J., Xu, G., Qian, J., Liao, G., Lin, Y., Pan, M., Zheng, B., Yuan, W., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1704347 · Cited by 6
Metadata
- Authors
- Lee, C., Yi, J., Park, J., Ahn, B., Won, Y.-W., Jeon, J., Lee, B. J., Cho, W. J., & Park, J. W.
- Affiliations
- University of Ulsan (KR)
- Gwangju Institute of Science and Technology (KR)
- University of North Texas (US)
- Corresponding author
- Park, Jihwan
- Cho, Wha Ja
- Park, Jeong Woo
- Venue
- Cell Death & Disease
- Published
- 2024-01-16
- Volume
- 15
- Issue
- 1
- Pages
- 56-56
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC10789740
- OpenAlex
- W4390909200
- Cited by
- 9
- References
- 55
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 1
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of North Texas Digital Library (University of North Texas) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (NRF-2014R1A6A1030318, NRF-2021R1I1A304950813)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Hedgehog signaling, KRAS G12C inhibitors, acquired drug resistance, Gli1, primary cilia, AURKA, lung adenocarcinoma, Smoothened inhibitors
- MeSH terms
- Humans, Lung Neoplasms, Mutation, Proto-Oncogene Proteins p21(ras), RNA, Small Interfering, Hedgehog Proteins, Aurora Kinase A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.